With over 20 years of experience in the CDMO industry, Stevens has led high-performing teams across biologics, sterile, and drug-product manufacturing. Read More >>
Polymeric excipients are essential to controlled drug release in LAIs, yet excipient selection remains complex. In this February 10th webinar, USP experts outline an integrated framework for LG polymer naming and characterization, review current USP standards, and share emerging tools designed to support quality, consistency, and regulatory confidence.
Looking at the critical challenges of developing bispecific antibodies, and how the use of comprehensive tailored approaches can enhance their productivity, stability, quality, and more.
Drawing insights from industry leaders and results from an in-depth Contract Pharma reader survey, this eBook provides a timely snapshot of what matters most to today’s packaging decision-makers.
Aphena Pharma Solutions is service provider in the pharmaceutical, medical device and biologics industries. Through excellence and innovation, we provide clients with a full range of pharmaceutical packaging and manufacturing services to advance their products to market–complete, on time, on budget. With our continued investment in technology, advanced packaging systems and rigorous cost control, Aphena can deliver solutions that are highly cost effective as well as comprehensive. Through every step in the product launch or transfer process including laboratory support, manufacturing, packaging and distribution, we provide clients with pharmaceutical services to help ensure a successful product launch and year-over-year growth.
UI Pharmaceuticals, an FDA-registered, university-affiliated pharmaceutical manufacturing facility, has been a trusted partner since 1974. We provide comprehensive development, manufacturing, and testing services for sterile solutions, lyophilized products, tablets, capsules, and other forms, ensuring quality, compliance, and client satisfaction.
